U.S., European Courts Deal Another Blow to AstraZeneca's Ulcer Drug
Courts in Europe and the U.S. dealt further setbacks for AstraZeneca's efforts to extend patent rights to an ulcer treatment that was once the world's best-selling drug....To view the full article, register now.
Already a subscriber? Click here to view full article